NCT06920563 Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
| NCT ID | NCT06920563 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ochsner Health System |
| Condition | Pre-Eclampsia; Complicating Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 296 participants |
| Start Date | 2025-03-17 |
| Primary Completion | 2026-10-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 296 participants in total. It began in 2025-03-17 with a primary completion date of 2026-10-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes? Participants will: View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum
Eligibility Criteria
Inclusion Criteria: 1. Age of at least 18 years. 2. Postpartum status. 3. Experience new-onset hypertension during pregnancy. 4. Enrollment in Connected MOM. 5. Ability to provide informed consent. 6. Establish medical care within the Ochsner System to facilitate data collection. Exclusion Criteria: 1. History of preeclampsia or gestational hypertension during previous pregnancy 2. History of chronic hypertension 3. History of coronary artery disease (myocardial infarction, coronary stent placement, coronary artery bypass grafting, spontaneous coronary artery dissection) 4. History of ischemic CVA 5. History of Congestive heart failure 6. Renal dysfunction 7. Liver dysfunction 8. Left ventricular dysfunction 9. Congenital heart disease 10. Still birth at delivery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06920563 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pre-Eclampsia; Complicating Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06920563 currently recruiting?
Yes, NCT06920563 is actively recruiting participants. Contact the research team at salima.qamruddin@ochsner.org for enrollment information.
Where is the NCT06920563 trial being conducted?
This trial is being conducted at New Orleans, United States.
Who is sponsoring the NCT06920563 clinical trial?
NCT06920563 is sponsored by Ochsner Health System. The trial plans to enroll 296 participants.